Showing 27,481 - 27,500 results of 45,793 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.95s Refine Results
  1. 27481

    Model example of exponential decay of temporal masking thresholds (normalized to amplitude of 1) at two different temporal masking half-lifes <i>T</i><sub><i>½</i></sub> (0.5 ms in... by Eugen Kludt (9962590)

    Published 2021
    “…At this stimulation rate, <i>T</i><sub><i>½</i></sub> of 0.5 ms or 1.1 ms leads to a decrease of the temporal masking threshold by 50% or 20% in the following frame, respectively.…”
  2. 27482

    Phages and <i>Campylobacter</i> isolated on farm 1 and distribution of gamma glutamyl transferase activity. by Sophie Kittler (288095)

    Published 2014
    “…<p>A significant decrease of log<sub>10</sub> 1.8 cfu/g in mean <i>Campylobacter</i> counts took place in the investigated flock 2 from day 35 to day 38 (p = 0.00078).…”
  3. 27483

    Results summary. by Ana María Rodríguez (162621)

    Published 2012
    “…<p>SD<sub>50</sub>: sensitizing dose of peptide concentration required to induce half-maximum of the maximum number of specific IFN-γ secreting cells.…”
  4. 27484

    Oligodendroglioma cells produce 2HG in culture. by Barbara Klink (391506)

    Published 2013
    “…Measurements were made in triplicate. The decrease in 2HG concentrations is concomitant with the removal of approximately 50% of the spheres for implantation in between the 21- and 28-day time points.…”
  5. 27485

    The effects of adolescent alcohol on adolescent risk preference. by Matthew S. McMurray (595103)

    Published 2014
    “…Both Control and EtOH-Low animals showed decreasing risk preference over continued exposure to variable risk, while EtOH-High animals showed no decrease in risk preference over time (C). …”
  6. 27486

    The Impact of Racial and Ethnic Health Disparities in Diabetes Management on Clinical Outcomes: A Reinforcement Learning Analysis of Health Inequity Among Youth and Young Adults in... by Anna R. Kahkoska (3614780)

    Published 2021
    “…</p> <p><b>Results: </b>The study included n=978 YYA. The sample was 47.5% female and77.5% non-Hispanic White, with mean age 12.8±2.4 years at diagnosis. …”
  7. 27487

    Comparison of the Dynesys Dynamic Stabilization System and Posterior Lumbar Interbody Fusion for Lumbar Degenerative Disease by Yang Zhang (30734)

    Published 2016
    “…</p><p>Results</p><p>The mean follow-up time in the Dynesys group was 53.6 ± 5.3 months, while that in the PLIF group was 55.2 ± 6.8 months. …”
  8. 27488

    The effect of (+)-pentazocine and H<sub>2</sub>O<sub>2</sub> on ONHAs viability. by Jing Zhao (21160)

    Published 2017
    “…At the highest concentration of PTZ (50μM), there was a trend toward decrease in viability that was not significant. …”
  9. 27489

    sTLR2 significantly inhibits HIV-1 infection in reporter assay. by Bethany M. Henrick (292108)

    Published 2013
    “…A significant decrease (<i>P<0.001</i>) in HIV infection was observed in cells exposed to mock-D BM. …”
  10. 27490
  11. 27491
  12. 27492
  13. 27493
  14. 27494
  15. 27495
  16. 27496
  17. 27497
  18. 27498

    Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution by Oliver Grottke (584154)

    Published 2019
    “…Idarucizumab was then administered intravenously (30 mg/kg) and serial blood samples were taken for up to 24 hours to measure diluted thrombin time (corresponding with dabigatran activity), total dabigatran (bound to antidote and free drug) and a panel of coagulation parameters.</p><p>Results</p><p>Mean plasma dabigatran levels were 617 ± 16 ng/mL after infusion and 600 ± 114 ng/mL after ~50% hemodilution with no significant differences between groups. …”
  19. 27499
  20. 27500